SELLAS Life Sciences controversies

Galena stock-promotion controversy

Investigative reporting alleged that Galena paid MissionIR and the DreamTeam brand to promote its stock through articles whose financial relationship with the company was not adequately disclosed. Galena acknowledged the relationship and disclosed an SEC investigation. The disclosures were followed by a sharp share-price decline, shareholder lawsuits, and broader scrutiny of promotional practices in biotechnology. The controversy concerns the Galena predecessor but is relevant to the history of the public company that later became SELLAS.